Focusing On Actionable Genetic Intelligence & Pharmacogenomic Best Practice Design

Genomics Enable Safer And More Effective Drug Therapies

For almost two decades the National Institutes of Health’s National Institute of General Medical Sciences has been focused on the discovery and translation in genomics in order to enable safer and more effective drug therapies. Their focus includes insights into mechanisms related to genomic variation, to differences in drug response, the utility of genomic information to improve outcomes for drug therapies, and the incorporation of genomic data to predict and personalize medicine use into routine clinical practice.

Pharmacogenomics Enables Accurate Prescribing Decisions

We now know, by utilizing Pharmacogenomics, that one treatment regimen may work well for one individual, but not for another.  We know why and how to make more accurate prescribing decisions.

Not only can Pharmacogenomics reduce hospital readmissions, reduce patient burden, and improve performance scoring, it also saves lives by avoiding adverse drug reactions (ADE’s).

Moreover, at an enterprise level, if you project this knowledge across an entire patient population you can have a substantive effect on a large scale.

Geneticision Prescription Decision Support Analytics

Ask us about our Geneticision Prescription Decision Support Analytics and learn more about applying Pharmacogenomic decision making across your patient populations, and discover how you can provide better and less expensive care.

Contact

Coastal Lab Partners LLC

747 Main Street, Suite 112
Concord, MA 01742

857.366.7743
info@coastalpgx.com

Coastal Lab Partners LinkedIn Logo

COASTAL LAB PARTNERS | COPYRIGHT © 2016 COASTAL LAB PARTNERS, LLC. | PRIVACY AND TERMS OF USE | INFO@COASTALPGX.COM